Caspofungin for the treatment of candidaemia in patients with haematological malignancies.

Article English OPEN
Pagano L; Fianchi L; Fanci R; Candoni A; Caira M; Posteraro B; Morselli M; Valentini CG; Farina G; Mitra ME; Offidani M; Sanguinetti M; Tosti ME; Nosari A; Leone G; Viale P;
  • Publisher: Elsevier BV
  • Journal: Clinical Microbiology and Infection,volume 16,issue 3,pages298-301 (issn: 1198-743X)
  • Related identifiers: doi: 10.1111/j.1469-0691.2009.02832.x
  • Subject: Infectious Diseases | Microbiology (medical) | caspofungin

This study was prospectively conducted in 11 haematology divisions over a 2-year period to evaluate the efficacy of caspofungin in 24 neutropenic patients with haematological malignancies (HM) and candidaemia. These patients had received chemotherapy for HM and were neu... View more